Tender detail
Non-exclusive rebate agreement for the active substance hydroxycarbamide
Summary
The tender concerns the award of a non-exclusive rebate agreement for the active substance hydroxycarbamide (only dosage form FTA) for the period 01/08/2026 to 31/07/2028, with an option to extend once by 12 months. Bidders should note that DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible, and the exact participation and contract conditions must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.